***Please note we are now at capacity for this venue, therefore if you would like to be added to our waitlist please email [email protected]***
The life sciences sector is strategically important to UK plc and is already one of the most productive and innovative sectors of the economy. Our future success depends on it flourishing even further, which means creating an environment which enables the many successful life science companies that launch in UK to stay for the long-term, rather than relocate to other markets with better scaling opportunities or access to investment.
Join One Nucleus and RiverLabs at the Wellcome Collection for this event featuring former science Minister George Freeman MP’s first keynote speech since leaving office and a panel of life science experts and entrepreneurs, to explore what should be done to make the UK a scale-up market of choice. It will consider what are the key factors that influence companies’ decisions on where to locate, whether they are home-grown or global businesses, and ask what policy, investment and other changes can ensure the UK is as attractive and internationally competitive as possible.
18.00 – Registration and Networking
18.30 – Welcome from Riverlabs
18.40 – Keynote Speaker: George Freeman, Former Minister of State in the Department for Science, Innovation and Technology
19.00 – Panel discussion moderated by Lord O’Shaughnessy
Pam Garside, Chair, Cambridge Angels
Barbara Domayne-Hayman, KQ Labs Chair & Entrepreneur in Residence, The Francis Crick Institute
Charles Large, Founder & CEO, Autifony
Baroness Blackwood, Former Parliamentary Under Secretary of State at the Department of Health and Social Care
Sarah Blagden, Professor of Experimental Oncology at University of Oxford, Founder of RNA Guardian
19.45 – Q&A with the speakers
20.00 - Closing Remarks, Lord O’Shaughnessy
20.05 – Networking Reception
21.00 - Close
How Can the UK Become the Best Place to Scale a Life Science Company?
183 Euston Road
London, London NW1 2BE
United Kingdom